Oprah Winfrey shares her transformative weight-loss journey with GLP-1 medications, challenging societal perceptions of willpower and obesity in a candid podcast conversation with Dr. Ania Jastreboff.

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Oprah Winfrey has shared the surprising discovery she made about "thin people" due to her experience with Ozempic.

Oprah Winfrey has sparked controversy after making a provocative statement about 'thin people' while discussing her own weight-loss journey.While conversing with Dr. Ania Jastreboff on The Oprah ...

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

In a candid conversation on her podcast, Oprah Winfrey shared how she once believed that people who maintained a thin figure had more willpower ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...